Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Tarantino

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2026
Erratum: Rise and Fall of Neoadjuvant Carboplatin for Human Epidermal Growth Factor Receptor 2-Positive Breast CancerPaolo Tarantino
Clinical Advances in Hematology & Oncology : H&O|December 5, 2022
Lessons from recent trials of antibody-drug conjugates in breast cancerPaolo Tarantino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
Rise and Fall of Neoadjuvant Carboplatin for Human Epidermal Growth Factor Receptor 2-Positive Breast CancerPaolo Tarantino
Breast Cancer Research and Treatment|February 26, 2021
Activity of novel anti-HER2 agents for breast cancer based on hormone receptors expressionPaolo Tarantino, Giuseppe Curigliano
The New England Journal of Medicine|August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular CarcinomaPaolo Tarantino, Giuseppe Curigliano
Translational Lung Cancer Research|January 20, 2025
Patient-focused insights: how emotional distress shapes immunotherapy response in non-small cell lung cancerFederica Pecci, Paolo Tarantino
Expert Opinion on Biological Therapy|March 21, 2019
Defining the immunogram of breast cancer: a focus on clinical trialsPaolo Tarantino, Giuseppe Curigliano
Lancet (London, England)|October 13, 2024
Progress in breast cancer managementPaolo Tarantino, Sara M Tolaney
Cancer Discovery|February 6, 2026
Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast CancerTess A O'Meara, Paolo Tarantino
Cancer Research|October 17, 2022
The Dawn of the Antibody-Drug Conjugates Era: How T-DM1 Reinvented the Future of Chemotherapy for Solid TumorsPaolo Tarantino, Sara M Tolaney
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2026
Erratum: Rise and Fall of Neoadjuvant Carboplatin for Human Epidermal Growth Factor Receptor 2-Positive Breast CancerPaolo Tarantino
Clinical Advances in Hematology & Oncology : H&O|December 5, 2022
Lessons from recent trials of antibody-drug conjugates in breast cancerPaolo Tarantino
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2026
Rise and Fall of Neoadjuvant Carboplatin for Human Epidermal Growth Factor Receptor 2-Positive Breast CancerPaolo Tarantino
Breast Cancer Research and Treatment|February 26, 2021
Activity of novel anti-HER2 agents for breast cancer based on hormone receptors expressionPaolo Tarantino, Giuseppe Curigliano
The New England Journal of Medicine|August 14, 2020
Atezolizumab and Bevacizumab in Hepatocellular CarcinomaPaolo Tarantino, Giuseppe Curigliano
Translational Lung Cancer Research|January 20, 2025
Patient-focused insights: how emotional distress shapes immunotherapy response in non-small cell lung cancerFederica Pecci, Paolo Tarantino
Expert Opinion on Biological Therapy|March 21, 2019
Defining the immunogram of breast cancer: a focus on clinical trialsPaolo Tarantino, Giuseppe Curigliano
Lancet (London, England)|October 13, 2024
Progress in breast cancer managementPaolo Tarantino, Sara M Tolaney
Cancer Discovery|February 6, 2026
Different Diseases, Different Escapes: Trastuzumab Deruxtecan Resistance in HER2-Amplified versus HER2-Low Breast CancerTess A O'Meara, Paolo Tarantino
Cancer Research|October 17, 2022
The Dawn of the Antibody-Drug Conjugates Era: How T-DM1 Reinvented the Future of Chemotherapy for Solid TumorsPaolo Tarantino, Sara M Tolaney
Pageof 15